nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—lung cancer—liver cancer	0.303	1	CtDrD
Cisplatin—ATP7B—liver cancer	0.178	0.549	CbGaD
Cisplatin—GSTM1—liver cancer	0.0759	0.234	CbGaD
Cisplatin—GSTP1—liver cancer	0.0702	0.217	CbGaD
Cisplatin—NQO1—Doxorubicin—liver cancer	0.0501	0.235	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—liver cancer	0.0419	0.197	CbGbCtD
Cisplatin—XDH—Doxorubicin—liver cancer	0.0262	0.123	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—liver cancer	0.0201	0.0946	CbGbCtD
Cisplatin—ABCC2—Sorafenib—liver cancer	0.0151	0.0709	CbGbCtD
Cisplatin—ABCG2—Sorafenib—liver cancer	0.0136	0.0641	CbGbCtD
Cisplatin—CYP2B6—Sorafenib—liver cancer	0.00959	0.0451	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—liver cancer	0.00915	0.043	CbGbCtD
Cisplatin—MPO—superior mesenteric artery—liver cancer	0.0085	0.232	CbGeAlD
Cisplatin—ABCG2—Doxorubicin—liver cancer	0.00827	0.0389	CbGbCtD
Cisplatin—ABCC2—bile canaliculus—liver cancer	0.00779	0.213	CbGeAlD
Cisplatin—CYP2B6—Doxorubicin—liver cancer	0.00582	0.0273	CbGbCtD
Cisplatin—CYP2C9—Sorafenib—liver cancer	0.00507	0.0238	CbGbCtD
Cisplatin—ABCB1—Sorafenib—liver cancer	0.00492	0.0231	CbGbCtD
Cisplatin—ABCC3—bile duct—liver cancer	0.00305	0.0833	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—liver cancer	0.00298	0.014	CbGbCtD
Cisplatin—ABCC2—bile duct—liver cancer	0.00243	0.0665	CbGeAlD
Cisplatin—BCHE—diaphragm—liver cancer	0.00212	0.0581	CbGeAlD
Cisplatin—ABCC2—bile—liver cancer	0.00187	0.0511	CbGeAlD
Cisplatin—MT2A—gall bladder—liver cancer	0.00143	0.0392	CbGeAlD
Cisplatin—NQO1—gall bladder—liver cancer	0.000724	0.0198	CbGeAlD
Cisplatin—ABCC3—gall bladder—liver cancer	0.00065	0.0178	CbGeAlD
Cisplatin—GSTP1—gall bladder—liver cancer	0.000647	0.0177	CbGeAlD
Cisplatin—MT1A—liver—liver cancer	0.000504	0.0138	CbGeAlD
Cisplatin—CYP4A11—liver—liver cancer	0.000465	0.0127	CbGeAlD
Cisplatin—ATP7B—liver—liver cancer	0.000452	0.0124	CbGeAlD
Cisplatin—MT2A—liver—liver cancer	0.00042	0.0115	CbGeAlD
Cisplatin—SLC31A2—liver—liver cancer	0.000413	0.0113	CbGeAlD
Cisplatin—GSTT1—liver—liver cancer	0.000411	0.0112	CbGeAlD
Cisplatin—GSTP1—embryo—liver cancer	0.00041	0.0112	CbGeAlD
Cisplatin—Neuropathy—Sorafenib—liver cancer	0.000379	0.00763	CcSEcCtD
Cisplatin—ATP7A—liver—liver cancer	0.000364	0.00995	CbGeAlD
Cisplatin—Neurotoxicity—Doxorubicin—liver cancer	0.000356	0.00717	CcSEcCtD
Cisplatin—ABCC6—liver—liver cancer	0.000334	0.00913	CbGeAlD
Cisplatin—Cardiac failure congestive—Sorafenib—liver cancer	0.000323	0.00651	CcSEcCtD
Cisplatin—SOD1—liver—liver cancer	0.000318	0.00871	CbGeAlD
Cisplatin—Myelosuppression—Epirubicin—liver cancer	0.000318	0.00641	CcSEcCtD
Cisplatin—Renal failure acute—Sorafenib—liver cancer	0.000318	0.00639	CcSEcCtD
Cisplatin—SLC31A1—liver—liver cancer	0.00031	0.00848	CbGeAlD
Cisplatin—XDH—liver—liver cancer	0.000307	0.00838	CbGeAlD
Cisplatin—GSTM1—liver—liver cancer	0.000303	0.00828	CbGeAlD
Cisplatin—PTGS2—gall bladder—liver cancer	0.000302	0.00825	CbGeAlD
Cisplatin—Myelosuppression—Doxorubicin—liver cancer	0.000295	0.00593	CcSEcCtD
Cisplatin—Hyponatraemia—Sorafenib—liver cancer	0.000294	0.00592	CcSEcCtD
Cisplatin—Venous thrombosis—Epirubicin—liver cancer	0.000277	0.00557	CcSEcCtD
Cisplatin—Dehydration—Sorafenib—liver cancer	0.000273	0.00549	CcSEcCtD
Cisplatin—Blindness—Epirubicin—liver cancer	0.00027	0.00543	CcSEcCtD
Cisplatin—Hypokalaemia—Sorafenib—liver cancer	0.000267	0.00537	CcSEcCtD
Cisplatin—Breast disorder—Sorafenib—liver cancer	0.000265	0.00533	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000264	0.00531	CcSEcCtD
Cisplatin—Nasopharyngitis—Sorafenib—liver cancer	0.000262	0.00528	CcSEcCtD
Cisplatin—Hypophosphataemia—Epirubicin—liver cancer	0.000257	0.00517	CcSEcCtD
Cisplatin—Venous thrombosis—Doxorubicin—liver cancer	0.000256	0.00515	CcSEcCtD
Cisplatin—Generalised oedema—Epirubicin—liver cancer	0.000251	0.00505	CcSEcCtD
Cisplatin—Blindness—Doxorubicin—liver cancer	0.000249	0.00502	CcSEcCtD
Cisplatin—Pancreatitis—Sorafenib—liver cancer	0.000248	0.005	CcSEcCtD
Cisplatin—Febrile neutropenia—Epirubicin—liver cancer	0.000248	0.00499	CcSEcCtD
Cisplatin—Abdominal discomfort—Sorafenib—liver cancer	0.000243	0.00489	CcSEcCtD
Cisplatin—Serum creatinine increased—Epirubicin—liver cancer	0.000243	0.00488	CcSEcCtD
Cisplatin—Optic neuritis—Epirubicin—liver cancer	0.000243	0.00488	CcSEcCtD
Cisplatin—Hypophosphataemia—Doxorubicin—liver cancer	0.000238	0.00478	CcSEcCtD
Cisplatin—Generalised oedema—Doxorubicin—liver cancer	0.000232	0.00467	CcSEcCtD
Cisplatin—Febrile neutropenia—Doxorubicin—liver cancer	0.00023	0.00462	CcSEcCtD
Cisplatin—ABCC5—liver—liver cancer	0.000227	0.0062	CbGeAlD
Cisplatin—Optic neuritis—Doxorubicin—liver cancer	0.000225	0.00452	CcSEcCtD
Cisplatin—Serum creatinine increased—Doxorubicin—liver cancer	0.000225	0.00452	CcSEcCtD
Cisplatin—Acute coronary syndrome—Sorafenib—liver cancer	0.000223	0.00448	CcSEcCtD
Cisplatin—Renal failure—Sorafenib—liver cancer	0.000222	0.00447	CcSEcCtD
Cisplatin—Neuropathy peripheral—Sorafenib—liver cancer	0.000221	0.00446	CcSEcCtD
Cisplatin—Myocardial infarction—Sorafenib—liver cancer	0.000221	0.00446	CcSEcCtD
Cisplatin—Stomatitis—Sorafenib—liver cancer	0.00022	0.00443	CcSEcCtD
Cisplatin—Hepatobiliary disease—Sorafenib—liver cancer	0.000214	0.0043	CcSEcCtD
Cisplatin—NQO1—liver—liver cancer	0.000212	0.0058	CbGeAlD
Cisplatin—Urinary tract disorder—Sorafenib—liver cancer	0.0002	0.00403	CcSEcCtD
Cisplatin—Connective tissue disorder—Sorafenib—liver cancer	0.000199	0.00401	CcSEcCtD
Cisplatin—Urethral disorder—Sorafenib—liver cancer	0.000199	0.004	CcSEcCtD
Cisplatin—MPO—liver—liver cancer	0.000195	0.00534	CbGeAlD
Cisplatin—PTGS2—embryo—liver cancer	0.000191	0.00523	CbGeAlD
Cisplatin—ABCC3—liver—liver cancer	0.000191	0.00521	CbGeAlD
Cisplatin—Necrosis—Epirubicin—liver cancer	0.00019	0.00383	CcSEcCtD
Cisplatin—GSTP1—liver—liver cancer	0.00019	0.00519	CbGeAlD
Cisplatin—Tinnitus—Sorafenib—liver cancer	0.000189	0.00381	CcSEcCtD
Cisplatin—Abscess—Epirubicin—liver cancer	0.000189	0.0038	CcSEcCtD
Cisplatin—Flushing—Sorafenib—liver cancer	0.000188	0.00379	CcSEcCtD
Cisplatin—Cardiac disorder—Sorafenib—liver cancer	0.000188	0.00379	CcSEcCtD
Cisplatin—Ageusia—Epirubicin—liver cancer	0.000184	0.00371	CcSEcCtD
Cisplatin—Immune system disorder—Sorafenib—liver cancer	0.000183	0.00369	CcSEcCtD
Cisplatin—Mediastinal disorder—Sorafenib—liver cancer	0.000183	0.00368	CcSEcCtD
Cisplatin—Arrhythmia—Sorafenib—liver cancer	0.000181	0.00365	CcSEcCtD
Cisplatin—Alopecia—Sorafenib—liver cancer	0.000179	0.00361	CcSEcCtD
Cisplatin—Liver injury—Epirubicin—liver cancer	0.000177	0.00357	CcSEcCtD
Cisplatin—Malnutrition—Sorafenib—liver cancer	0.000177	0.00355	CcSEcCtD
Cisplatin—Erythema—Sorafenib—liver cancer	0.000177	0.00355	CcSEcCtD
Cisplatin—Necrosis—Doxorubicin—liver cancer	0.000176	0.00354	CcSEcCtD
Cisplatin—Abscess—Doxorubicin—liver cancer	0.000175	0.00351	CcSEcCtD
Cisplatin—Extravasation—Epirubicin—liver cancer	0.000171	0.00344	CcSEcCtD
Cisplatin—Ageusia—Doxorubicin—liver cancer	0.00017	0.00343	CcSEcCtD
Cisplatin—Muscle spasms—Sorafenib—liver cancer	0.00017	0.00342	CcSEcCtD
Cisplatin—Cellulitis—Epirubicin—liver cancer	0.000164	0.0033	CcSEcCtD
Cisplatin—Liver injury—Doxorubicin—liver cancer	0.000164	0.0033	CcSEcCtD
Cisplatin—Anaemia—Sorafenib—liver cancer	0.000163	0.00328	CcSEcCtD
Cisplatin—Hyperuricaemia—Epirubicin—liver cancer	0.000161	0.00324	CcSEcCtD
Cisplatin—Extravasation—Doxorubicin—liver cancer	0.000158	0.00319	CcSEcCtD
Cisplatin—Leukopenia—Sorafenib—liver cancer	0.000158	0.00318	CcSEcCtD
Cisplatin—Dysarthria—Epirubicin—liver cancer	0.000158	0.00318	CcSEcCtD
Cisplatin—Ulcer—Epirubicin—liver cancer	0.000158	0.00318	CcSEcCtD
Cisplatin—ABCC2—liver—liver cancer	0.000152	0.00416	CbGeAlD
Cisplatin—Blood uric acid increased—Epirubicin—liver cancer	0.000152	0.00306	CcSEcCtD
Cisplatin—Cellulitis—Doxorubicin—liver cancer	0.000152	0.00306	CcSEcCtD
Cisplatin—Myalgia—Sorafenib—liver cancer	0.00015	0.00303	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000149	0.003	CcSEcCtD
Cisplatin—Hiccups—Epirubicin—liver cancer	0.000149	0.003	CcSEcCtD
Cisplatin—Hepatocellular injury—Epirubicin—liver cancer	0.000149	0.003	CcSEcCtD
Cisplatin—Hyperuricaemia—Doxorubicin—liver cancer	0.000149	0.003	CcSEcCtD
Cisplatin—Hyperkalaemia—Epirubicin—liver cancer	0.000147	0.00295	CcSEcCtD
Cisplatin—Dysarthria—Doxorubicin—liver cancer	0.000146	0.00294	CcSEcCtD
Cisplatin—Ulcer—Doxorubicin—liver cancer	0.000146	0.00294	CcSEcCtD
Cisplatin—Anaphylactic shock—Sorafenib—liver cancer	0.000144	0.0029	CcSEcCtD
Cisplatin—Infection—Sorafenib—liver cancer	0.000143	0.00288	CcSEcCtD
Cisplatin—Skin exfoliation—Epirubicin—liver cancer	0.000142	0.00287	CcSEcCtD
Cisplatin—Fluid retention—Epirubicin—liver cancer	0.000142	0.00285	CcSEcCtD
Cisplatin—Nervous system disorder—Sorafenib—liver cancer	0.000141	0.00284	CcSEcCtD
Cisplatin—Thrombocytopenia—Sorafenib—liver cancer	0.000141	0.00284	CcSEcCtD
Cisplatin—Blood uric acid increased—Doxorubicin—liver cancer	0.000141	0.00283	CcSEcCtD
Cisplatin—Neuropathy—Epirubicin—liver cancer	0.00014	0.00282	CcSEcCtD
Cisplatin—Skin disorder—Sorafenib—liver cancer	0.00014	0.00282	CcSEcCtD
Cisplatin—Hiccups—Doxorubicin—liver cancer	0.000138	0.00278	CcSEcCtD
Cisplatin—Hepatocellular injury—Doxorubicin—liver cancer	0.000138	0.00278	CcSEcCtD
Cisplatin—Anorexia—Sorafenib—liver cancer	0.000137	0.00276	CcSEcCtD
Cisplatin—Hyperkalaemia—Doxorubicin—liver cancer	0.000136	0.00273	CcSEcCtD
Cisplatin—Skin exfoliation—Doxorubicin—liver cancer	0.000132	0.00265	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000131	0.00264	CcSEcCtD
Cisplatin—Fluid retention—Doxorubicin—liver cancer	0.000131	0.00264	CcSEcCtD
Cisplatin—Neuropathy—Doxorubicin—liver cancer	0.00013	0.00261	CcSEcCtD
Cisplatin—Dyspnoea—Sorafenib—liver cancer	0.000128	0.00259	CcSEcCtD
Cisplatin—Phlebitis—Epirubicin—liver cancer	0.000126	0.00253	CcSEcCtD
Cisplatin—Decreased appetite—Sorafenib—liver cancer	0.000125	0.00252	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000124	0.0025	CcSEcCtD
Cisplatin—Pain—Sorafenib—liver cancer	0.000123	0.00248	CcSEcCtD
Cisplatin—Cardiac failure congestive—Epirubicin—liver cancer	0.000119	0.0024	CcSEcCtD
Cisplatin—ABCB1—embryo—liver cancer	0.000118	0.00324	CbGeAlD
Cisplatin—Renal failure acute—Epirubicin—liver cancer	0.000117	0.00236	CcSEcCtD
Cisplatin—Phlebitis—Doxorubicin—liver cancer	0.000116	0.00234	CcSEcCtD
Cisplatin—BCHE—liver—liver cancer	0.000115	0.00314	CbGeAlD
Cisplatin—Body temperature increased—Sorafenib—liver cancer	0.000114	0.00229	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Epirubicin—liver cancer	0.000112	0.00225	CcSEcCtD
Cisplatin—ABCG2—liver—liver cancer	0.000111	0.00304	CbGeAlD
Cisplatin—Cerebrovascular accident—Epirubicin—liver cancer	0.000111	0.00223	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—liver cancer	0.000111	0.00223	CcSEcCtD
Cisplatin—Hyponatraemia—Epirubicin—liver cancer	0.000109	0.00219	CcSEcCtD
Cisplatin—Renal failure acute—Doxorubicin—liver cancer	0.000109	0.00219	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000108	0.00218	CcSEcCtD
Cisplatin—Hypersensitivity—Sorafenib—liver cancer	0.000106	0.00214	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—liver cancer	0.000105	0.00211	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000104	0.00208	CcSEcCtD
Cisplatin—Asthenia—Sorafenib—liver cancer	0.000103	0.00208	CcSEcCtD
Cisplatin—CYP2B6—liver—liver cancer	0.000102	0.0028	CbGeAlD
Cisplatin—Cerebrovascular accident—Doxorubicin—liver cancer	0.000102	0.00206	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—liver cancer	0.000101	0.00204	CcSEcCtD
Cisplatin—CYP2C9—liver—liver cancer	0.000101	0.00277	CbGeAlD
Cisplatin—Dehydration—Epirubicin—liver cancer	0.000101	0.00203	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—liver cancer	0.000101	0.00203	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.0001	0.00202	CcSEcCtD
Cisplatin—Orthostatic hypotension—Epirubicin—liver cancer	9.9e-05	0.00199	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—liver cancer	9.86e-05	0.00198	CcSEcCtD
Cisplatin—Diarrhoea—Sorafenib—liver cancer	9.86e-05	0.00198	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—liver cancer	9.79e-05	0.00197	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—liver cancer	9.76e-05	0.00196	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—liver cancer	9.69e-05	0.00195	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—liver cancer	9.68e-05	0.00195	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—liver cancer	9.39e-05	0.00189	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—liver cancer	9.32e-05	0.00188	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—liver cancer	9.18e-05	0.00185	CcSEcCtD
Cisplatin—Vomiting—Sorafenib—liver cancer	9.16e-05	0.00184	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—liver cancer	9.16e-05	0.00184	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—liver cancer	9.12e-05	0.00184	CcSEcCtD
Cisplatin—Rash—Sorafenib—liver cancer	9.08e-05	0.00183	CcSEcCtD
Cisplatin—Dermatitis—Sorafenib—liver cancer	9.08e-05	0.00183	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—liver cancer	9.06e-05	0.00182	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	9.03e-05	0.00182	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—liver cancer	8.96e-05	0.0018	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—liver cancer	8.89e-05	0.00179	CcSEcCtD
Cisplatin—PTGS2—liver—liver cancer	8.85e-05	0.00242	CbGeAlD
Cisplatin—Nausea—Sorafenib—liver cancer	8.56e-05	0.00172	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—liver cancer	8.49e-05	0.00171	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—liver cancer	8.23e-05	0.00166	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—liver cancer	8.21e-05	0.00165	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—liver cancer	8.18e-05	0.00165	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—liver cancer	8.14e-05	0.00164	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—liver cancer	8.12e-05	0.00163	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—liver cancer	7.9e-05	0.00159	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—liver cancer	7.63e-05	0.00154	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—liver cancer	7.59e-05	0.00153	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—liver cancer	7.57e-05	0.00152	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—liver cancer	7.53e-05	0.00152	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—liver cancer	7.51e-05	0.00151	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—liver cancer	7.4e-05	0.00149	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—liver cancer	7.37e-05	0.00148	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—liver cancer	7.35e-05	0.00148	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—liver cancer	7.31e-05	0.00147	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—liver cancer	7.22e-05	0.00145	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—liver cancer	7.06e-05	0.00142	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—liver cancer	7e-05	0.00141	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—liver cancer	6.99e-05	0.00141	CcSEcCtD
Cisplatin—Flushing—Epirubicin—liver cancer	6.96e-05	0.0014	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—liver cancer	6.96e-05	0.0014	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—liver cancer	6.85e-05	0.00138	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—liver cancer	6.81e-05	0.00137	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—liver cancer	6.8e-05	0.00137	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—liver cancer	6.77e-05	0.00136	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—liver cancer	6.75e-05	0.00136	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—liver cancer	6.7e-05	0.00135	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—liver cancer	6.68e-05	0.00135	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—liver cancer	6.62e-05	0.00133	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—liver cancer	6.52e-05	0.00131	CcSEcCtD
Cisplatin—Erythema—Epirubicin—liver cancer	6.52e-05	0.00131	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—liver cancer	6.48e-05	0.0013	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—liver cancer	6.47e-05	0.0013	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—liver cancer	6.44e-05	0.0013	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—liver cancer	6.44e-05	0.0013	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—liver cancer	6.43e-05	0.00129	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—liver cancer	6.27e-05	0.00126	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—liver cancer	6.26e-05	0.00126	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—liver cancer	6.25e-05	0.00126	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—liver cancer	6.2e-05	0.00125	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—liver cancer	6.15e-05	0.00124	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—liver cancer	6.13e-05	0.00123	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—liver cancer	6.05e-05	0.00122	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—liver cancer	6.04e-05	0.00122	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—liver cancer	6.04e-05	0.00122	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—liver cancer	6.03e-05	0.00121	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—liver cancer	5.95e-05	0.0012	CcSEcCtD
Cisplatin—Malaise—Epirubicin—liver cancer	5.88e-05	0.00118	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—liver cancer	5.84e-05	0.00118	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—liver cancer	5.8e-05	0.00117	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—liver cancer	5.69e-05	0.00115	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—liver cancer	5.65e-05	0.00114	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—liver cancer	5.6e-05	0.00113	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—liver cancer	5.58e-05	0.00112	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—liver cancer	5.55e-05	0.00112	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—liver cancer	5.54e-05	0.00111	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	5.52e-05	0.00111	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—liver cancer	5.49e-05	0.0011	CcSEcCtD
Cisplatin—ABCB1—liver—liver cancer	5.48e-05	0.0015	CbGeAlD
Cisplatin—Malaise—Doxorubicin—liver cancer	5.44e-05	0.0011	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—liver cancer	5.4e-05	0.00109	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—liver cancer	5.32e-05	0.00107	CcSEcCtD
Cisplatin—Oedema—Epirubicin—liver cancer	5.32e-05	0.00107	CcSEcCtD
Cisplatin—Infection—Epirubicin—liver cancer	5.29e-05	0.00106	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—liver cancer	5.23e-05	0.00105	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—liver cancer	5.22e-05	0.00105	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—liver cancer	5.21e-05	0.00105	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—liver cancer	5.2e-05	0.00105	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—liver cancer	5.17e-05	0.00104	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—liver cancer	5.15e-05	0.00104	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—liver cancer	5.14e-05	0.00103	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—liver cancer	5.12e-05	0.00103	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	5.1e-05	0.00103	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—liver cancer	5.08e-05	0.00102	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—liver cancer	5.08e-05	0.00102	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—liver cancer	4.98e-05	0.001	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—liver cancer	4.93e-05	0.000992	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—liver cancer	4.93e-05	0.000992	CcSEcCtD
Cisplatin—Infection—Doxorubicin—liver cancer	4.89e-05	0.000985	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—liver cancer	4.85e-05	0.000977	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—liver cancer	4.83e-05	0.000973	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—liver cancer	4.82e-05	0.000971	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—liver cancer	4.81e-05	0.000968	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—liver cancer	4.79e-05	0.000963	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—liver cancer	4.78e-05	0.000962	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—liver cancer	4.76e-05	0.000959	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—liver cancer	4.75e-05	0.000956	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—liver cancer	4.7e-05	0.000945	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—liver cancer	4.63e-05	0.000932	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—liver cancer	4.6e-05	0.000927	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—liver cancer	4.6e-05	0.000925	CcSEcCtD
Cisplatin—Pain—Epirubicin—liver cancer	4.55e-05	0.000917	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—liver cancer	4.49e-05	0.000904	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—liver cancer	4.42e-05	0.000891	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—liver cancer	4.39e-05	0.000884	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—liver cancer	4.39e-05	0.000883	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—liver cancer	4.28e-05	0.000862	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—liver cancer	4.25e-05	0.000856	CcSEcCtD
Cisplatin—Pain—Doxorubicin—liver cancer	4.21e-05	0.000848	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—liver cancer	4.21e-05	0.000847	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—liver cancer	4.06e-05	0.000817	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—liver cancer	3.92e-05	0.00079	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—liver cancer	3.89e-05	0.000784	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—liver cancer	3.82e-05	0.000769	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—liver cancer	3.64e-05	0.000733	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—liver cancer	3.63e-05	0.000731	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—liver cancer	3.54e-05	0.000712	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—liver cancer	3.39e-05	0.000682	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—liver cancer	3.37e-05	0.000679	CcSEcCtD
Cisplatin—Rash—Epirubicin—liver cancer	3.36e-05	0.000676	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—liver cancer	3.35e-05	0.000675	CcSEcCtD
Cisplatin—Nausea—Epirubicin—liver cancer	3.16e-05	0.000637	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—liver cancer	3.13e-05	0.000631	CcSEcCtD
Cisplatin—Rash—Doxorubicin—liver cancer	3.11e-05	0.000625	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—liver cancer	3.1e-05	0.000625	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—liver cancer	2.93e-05	0.000589	CcSEcCtD
Cisplatin—PTGS2—Disease—PSMD10—liver cancer	2.75e-06	3.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PSMA4—liver cancer	2.75e-06	3.7e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NR1H4—liver cancer	2.74e-06	3.69e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP2E1—liver cancer	2.73e-06	3.68e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CB—liver cancer	2.72e-06	3.67e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	2.7e-06	3.64e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTA3—liver cancer	2.69e-06	3.63e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CD—liver cancer	2.68e-06	3.62e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MTHFR—liver cancer	2.68e-06	3.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GOT2—liver cancer	2.67e-06	3.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.66e-06	3.58e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CPT1B—liver cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GLUL—liver cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ALB—liver cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CG—liver cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—liver cancer	2.64e-06	3.55e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARA—liver cancer	2.63e-06	3.54e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1B—liver cancer	2.62e-06	3.53e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	2.6e-06	3.51e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.59e-06	3.49e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYCS—liver cancer	2.58e-06	3.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HPGDS—liver cancer	2.58e-06	3.48e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	2.57e-06	3.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.56e-06	3.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NR1H4—liver cancer	2.56e-06	3.45e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—liver cancer	2.55e-06	3.44e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYCS—liver cancer	2.55e-06	3.44e-05	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—liver cancer	2.54e-06	3.42e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GGT1—liver cancer	2.53e-06	3.41e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GOT1—liver cancer	2.53e-06	3.41e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—liver cancer	2.52e-06	3.4e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTA3—liver cancer	2.51e-06	3.39e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GOT1—liver cancer	2.51e-06	3.38e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GGT1—liver cancer	2.51e-06	3.38e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HMOX1—liver cancer	2.48e-06	3.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.48e-06	3.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HPGDS—liver cancer	2.48e-06	3.34e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—liver cancer	2.48e-06	3.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.48e-06	3.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTA4—liver cancer	2.46e-06	3.32e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CB—liver cancer	2.44e-06	3.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.43e-06	3.27e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1A—liver cancer	2.42e-06	3.26e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTA2—liver cancer	2.4e-06	3.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.36e-06	3.18e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CB—liver cancer	2.34e-06	3.15e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.34e-06	3.15e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CD—liver cancer	2.33e-06	3.14e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTM1—liver cancer	2.32e-06	3.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTA1—liver cancer	2.31e-06	3.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.31e-06	3.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.31e-06	3.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GOT1—liver cancer	2.31e-06	3.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PSMD10—liver cancer	2.3e-06	3.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PSMA4—liver cancer	2.3e-06	3.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTA4—liver cancer	2.3e-06	3.1e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ALB—liver cancer	2.3e-06	3.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.29e-06	3.09e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NAT2—liver cancer	2.29e-06	3.08e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—liver cancer	2.27e-06	3.07e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—liver cancer	2.27e-06	3.06e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—liver cancer	2.25e-06	3.03e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CG—liver cancer	2.25e-06	3.03e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.25e-06	3.03e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HMOX1—liver cancer	2.24e-06	3.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTA2—liver cancer	2.24e-06	3.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GOT2—liver cancer	2.24e-06	3.02e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HMOX1—liver cancer	2.22e-06	2.99e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PSMD10—liver cancer	2.21e-06	2.98e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PSMA4—liver cancer	2.21e-06	2.98e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1A1—liver cancer	2.2e-06	2.96e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALDOB—liver cancer	2.19e-06	2.96e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—liver cancer	2.17e-06	2.93e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTA1—liver cancer	2.16e-06	2.91e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—liver cancer	2.16e-06	2.91e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GOT2—liver cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NAT2—liver cancer	2.14e-06	2.88e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PRKCE—liver cancer	2.13e-06	2.87e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.11e-06	2.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP2E1—liver cancer	2.1e-06	2.84e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CRABP1—liver cancer	2.09e-06	2.82e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.09e-06	2.82e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—liver cancer	2.09e-06	2.82e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—liver cancer	2.07e-06	2.79e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.05e-06	2.77e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALDOB—liver cancer	2.05e-06	2.76e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—liver cancer	2.05e-06	2.76e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.04e-06	2.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.04e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CB—liver cancer	2.03e-06	2.73e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP2E1—liver cancer	2.02e-06	2.73e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARA—liver cancer	2.01e-06	2.71e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—liver cancer	2.01e-06	2.7e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—liver cancer	2e-06	2.7e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—liver cancer	2e-06	2.7e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1A1—liver cancer	1.98e-06	2.67e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CD—liver cancer	1.98e-06	2.67e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYCS—liver cancer	1.97e-06	2.65e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1A1—liver cancer	1.96e-06	2.64e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CRABP1—liver cancer	1.95e-06	2.64e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—liver cancer	1.95e-06	2.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GGT1—liver cancer	1.93e-06	2.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GOT1—liver cancer	1.93e-06	2.6e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYCS—liver cancer	1.89e-06	2.55e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GGT1—liver cancer	1.86e-06	2.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GOT1—liver cancer	1.86e-06	2.5e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—H2AFX—liver cancer	1.85e-06	2.5e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—liver cancer	1.85e-06	2.5e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—liver cancer	1.85e-06	2.49e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HPGDS—liver cancer	1.83e-06	2.47e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—liver cancer	1.83e-06	2.46e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARA—liver cancer	1.81e-06	2.44e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.8e-06	2.43e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARA—liver cancer	1.79e-06	2.42e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.76e-06	2.37e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—liver cancer	1.73e-06	2.34e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—liver cancer	1.72e-06	2.33e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.72e-06	2.32e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—liver cancer	1.72e-06	2.32e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMOX1—liver cancer	1.71e-06	2.31e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HPGDS—liver cancer	1.71e-06	2.3e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—liver cancer	1.7e-06	2.3e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—liver cancer	1.7e-06	2.29e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.7e-06	2.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—liver cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—liver cancer	1.68e-06	2.26e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—liver cancer	1.67e-06	2.25e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—liver cancer	1.66e-06	2.24e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—liver cancer	1.66e-06	2.24e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMOX1—liver cancer	1.64e-06	2.22e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—liver cancer	1.63e-06	2.2e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PSMA4—liver cancer	1.63e-06	2.2e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PSMD10—liver cancer	1.63e-06	2.2e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—liver cancer	1.59e-06	2.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GOT2—liver cancer	1.59e-06	2.14e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—liver cancer	1.58e-06	2.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.55e-06	2.1e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—liver cancer	1.55e-06	2.09e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.55e-06	2.09e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—liver cancer	1.54e-06	2.07e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—liver cancer	1.53e-06	2.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.53e-06	2.06e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PSMA4—liver cancer	1.52e-06	2.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PSMD10—liver cancer	1.52e-06	2.05e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—liver cancer	1.51e-06	2.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—liver cancer	1.51e-06	2.04e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—liver cancer	1.51e-06	2.03e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—liver cancer	1.5e-06	2.02e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—liver cancer	1.49e-06	2.01e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2E1—liver cancer	1.49e-06	2.01e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—liver cancer	1.49e-06	2.01e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—liver cancer	1.48e-06	2e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GOT2—liver cancer	1.48e-06	2e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—liver cancer	1.45e-06	1.96e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—liver cancer	1.43e-06	1.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—liver cancer	1.41e-06	1.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—liver cancer	1.41e-06	1.9e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.41e-06	1.9e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYCS—liver cancer	1.39e-06	1.88e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2E1—liver cancer	1.39e-06	1.88e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—liver cancer	1.39e-06	1.88e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—liver cancer	1.39e-06	1.87e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARA—liver cancer	1.38e-06	1.86e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GOT1—liver cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GGT1—liver cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—liver cancer	1.36e-06	1.84e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—liver cancer	1.35e-06	1.83e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—liver cancer	1.35e-06	1.83e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—liver cancer	1.35e-06	1.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.35e-06	1.82e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—liver cancer	1.35e-06	1.82e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—liver cancer	1.33e-06	1.8e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—liver cancer	1.33e-06	1.79e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARA—liver cancer	1.33e-06	1.79e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—liver cancer	1.32e-06	1.78e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYCS—liver cancer	1.3e-06	1.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GOT1—liver cancer	1.28e-06	1.72e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GGT1—liver cancer	1.28e-06	1.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—liver cancer	1.24e-06	1.68e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.24e-06	1.67e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—liver cancer	1.24e-06	1.67e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—liver cancer	1.23e-06	1.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SERPINE1—liver cancer	1.23e-06	1.66e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—liver cancer	1.21e-06	1.64e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMOX1—liver cancer	1.21e-06	1.64e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—liver cancer	1.19e-06	1.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—liver cancer	1.18e-06	1.6e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—liver cancer	1.18e-06	1.59e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—liver cancer	1.16e-06	1.57e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—liver cancer	1.15e-06	1.55e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—liver cancer	1.14e-06	1.54e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—liver cancer	1.14e-06	1.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMOX1—liver cancer	1.13e-06	1.53e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—liver cancer	1.13e-06	1.52e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAF1—liver cancer	1.11e-06	1.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—liver cancer	1.1e-06	1.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTOR—liver cancer	1.08e-06	1.46e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—liver cancer	1.08e-06	1.46e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—liver cancer	1.07e-06	1.44e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—liver cancer	1.06e-06	1.42e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—liver cancer	1.05e-06	1.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—liver cancer	1.04e-06	1.4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—liver cancer	1.03e-06	1.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—liver cancer	1.02e-06	1.37e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—liver cancer	1.01e-06	1.36e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—liver cancer	1e-06	1.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—liver cancer	1e-06	1.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—liver cancer	9.98e-07	1.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—liver cancer	9.87e-07	1.33e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARA—liver cancer	9.8e-07	1.32e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—liver cancer	9.6e-07	1.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—liver cancer	9.38e-07	1.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—liver cancer	9.33e-07	1.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARA—liver cancer	9.15e-07	1.23e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—liver cancer	9.07e-07	1.22e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—liver cancer	8.72e-07	1.18e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—liver cancer	8.59e-07	1.16e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—liver cancer	8.39e-07	1.13e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—liver cancer	8.37e-07	1.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.22e-07	1.11e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—liver cancer	8.1e-07	1.09e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—liver cancer	8.03e-07	1.08e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—liver cancer	7.84e-07	1.06e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—liver cancer	7.78e-07	1.05e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—liver cancer	7.76e-07	1.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—liver cancer	7.56e-07	1.02e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—liver cancer	7.37e-07	9.94e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—liver cancer	7.28e-07	9.82e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—liver cancer	7.25e-07	9.77e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—liver cancer	7.18e-07	9.69e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—liver cancer	7.17e-07	9.67e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—liver cancer	6.89e-07	9.29e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—liver cancer	6.8e-07	9.17e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—liver cancer	6.6e-07	8.9e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—liver cancer	6.56e-07	8.85e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—liver cancer	6.43e-07	8.67e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—liver cancer	6.11e-07	8.23e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—liver cancer	6e-07	8.1e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—liver cancer	5.92e-07	7.98e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—liver cancer	5.86e-07	7.9e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—liver cancer	5.84e-07	7.88e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—liver cancer	5.53e-07	7.45e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—liver cancer	5.39e-07	7.27e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—liver cancer	5.31e-07	7.16e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—liver cancer	4.52e-07	6.09e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—liver cancer	4.34e-07	5.85e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—liver cancer	3.92e-07	5.28e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—liver cancer	3.66e-07	4.94e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—liver cancer	3.2e-07	4.32e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—liver cancer	2.99e-07	4.03e-06	CbGpPWpGaD
